Abbott Laboratories Balance Sheet Health
Financial Health criteria checks 6/6
Abbott Laboratories has a total shareholder equity of $39.0B and total debt of $14.7B, which brings its debt-to-equity ratio to 37.7%. Its total assets and total liabilities are $72.5B and $33.4B respectively. Abbott Laboratories's EBIT is $7.1B making its interest coverage ratio 27.3. It has cash and short-term investments of $6.7B.
Key information
37.7%
Debt to equity ratio
US$14.71b
Debt
Interest coverage ratio | 27.3x |
Cash | US$6.65b |
Equity | US$39.04b |
Total liabilities | US$33.42b |
Total assets | US$72.47b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ABT's short term assets ($22.4B) exceed its short term liabilities ($14.0B).
Long Term Liabilities: ABT's short term assets ($22.4B) exceed its long term liabilities ($19.4B).
Debt to Equity History and Analysis
Debt Level: ABT's net debt to equity ratio (20.6%) is considered satisfactory.
Reducing Debt: ABT's debt to equity ratio has reduced from 61.4% to 37.7% over the past 5 years.
Debt Coverage: ABT's debt is well covered by operating cash flow (48.6%).
Interest Coverage: ABT's interest payments on its debt are well covered by EBIT (27.3x coverage).